{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:18:55Z","timestamp":1787771935434,"version":"build-2784847793"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>Chemotherapy-induced alopecia (CIA) is the most common side effect of systemic treatment in breast cancer patients. Scalp cooling gained worldwide acceptance in preventing or mitigating CIA in patients undergoing chemotherapy. The objective of this study was to evaluate the efficacy and safety of the Paxman scalp cooling system (PSCS) in Indian breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This is a multi-centre, retrospective-observational study including patients registered from 1\n                      <jats:sup>st<\/jats:sup>\n                      March, 2019 to 30\n                      <jats:sup>th<\/jats:sup>\n                      April, 2021 undergoing chemotherapy for breast cancer by using PSCS. The primary end-point was the incidence of CIA after completing cycles of chemotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 91 female patients were enrolled in the study, with a median age of 53 years (IQR: 44\u201362 years). The prevention of alopecia (grade 0 and grade I) was seen in 81%, while more than 50% hair loss (grade 2) was seen in 16.48% after completion of treatment. The univariate analysis results showed that CIA was significantly higher in patients who received anthracyclines (OR: 2.69; 95% CI: 1.04\u20136.958;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.041) and in patients with a post-infusion cooling time of &gt;150 minutes (OR: 8.409; 95% CI: 2.295\u201330.787;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). The incidence of grade 2 (&gt;50% hair loss) alopecia was 81.3% in patients &lt;6 weeks and was 18.8% at &gt;6 weeks of start of chemotherapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). No adverse events were reported in 71.4% of patients, and the most common adverse event was headache (18.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PSCS is an effective and well-tolerated treatment modality for preventing CIA among breast cancer patients undergoing chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_345_23","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T07:01:34Z","timestamp":1709103694000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India \u2013 Multi-centre Retrospective Cohort Study"],"prefix":"10.4103","volume":"69","author":[{"given":"Mangesh","family":"Mekha","sequence":"first","affiliation":[{"name":"From the Department of Medical Oncology, Mumbai Oncocare Centre, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vashishth","family":"Maniar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udip","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam","family":"Kalaskar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Sheth","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Kendre","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Morzaria","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Korgavkar","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Mumbai Oncocare Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekhar","family":"Pethe","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Dhande","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mumbai Oncocare Centre, Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.3390\/cancers13215556","article-title":"Cancer-related alopecia:From etiologies to global management","volume":"13","author":"Quesada","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer:A 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5152\/FNJN.2021.19098","article-title":"The impact of the perception of chemotherapy-induced alopecia on psychosocial life","volume":"29","author":"\u00d6z\u00fcsa\u011flam","year":"2021","journal-title":"Florence Nightingale J Nurs"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00520-003-0562-5","article-title":"Chemotherapy-induced alopecia:Psychosocial impact and therapeutic approaches","volume":"12","author":"Hesketh","year":"2004","journal-title":"Support Care Cancer"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/apjon.apjon_8_20","article-title":"Giving a face to chemotherapy-induced alopecia:A feasibility study on drawings by patients","volume":"7","author":"van Alphen","year":"2020","journal-title":"Asia Pac J Oncol Nurs"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejon.2018.01.001","article-title":"Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia","volume":"33","author":"Komen","year":"2018","journal-title":"Eur J Oncol Nurs"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1529-8019.2011.01430.x","article-title":"Treatment of chemotherapy-induced alopecia","volume":"24","author":"Yeager","year":"2011","journal-title":"Dermatol Ther"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clbc.2015.01.003","article-title":"Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy","volume":"15","author":"Cigler","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1188\/17.CJON.226-233","article-title":"Scalp Cooling:A literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia","volume":"21","author":"Ross","year":"2017","journal-title":"Clin J Oncol Nurs"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1634\/theoncologist.2017-0263","article-title":"A clinical and biological guide for understanding chemotherapy-induced alopecia and its prevention","volume":"23","author":"Dunnill","year":"2018","journal-title":"Oncologist"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdi088","article-title":"Prevention of chemotherapy-induced hair loss by scalp cooling","volume":"16","author":"Grevelman","year":"2005","journal-title":"Ann Oncol"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00365518509155250","article-title":"Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man","volume":"45","author":"B\u00fclow","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/onco.13690","article-title":"Does scalp cooling have the same efficacy in black patients receiving chemotherapy for breast cancer?","volume":"26","author":"Dilawari","year":"2021","journal-title":"Oncologist"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/0284186X.2013.794955","article-title":"Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia","volume":"53","author":"van den Hurk","year":"2014","journal-title":"Acta Oncol"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/0284186X.2012.658966","article-title":"Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-Results of the Dutch scalp cooling registry","volume":"51","author":"van den Hurk","year":"2012","journal-title":"Acta Oncol"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2006.07409.x","article-title":"Follicular miniaturization in female pattern hair loss:Clinicopathological correlations","volume":"155","author":"Messenger","year":"2006","journal-title":"Br J Dermatol"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM197912273012605","article-title":"Prevention of doxorubicin-induced hair loss with scalp hypothermia","volume":"301","author":"Dean","year":"1979","journal-title":"N Engl J Med"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0738-3991(03)00040-5","article-title":"Cancer and stigma:Experience of patients with chemotherapy-induced alopecia","volume":"52","author":"Rosman","year":"2004","journal-title":"Patient Educ Couns"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2018.04.012","article-title":"Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline\/taxane-based chemotherapy","volume":"40","author":"Vasconcelos","year":"2018","journal-title":"Breast"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00520-013-1804-9","article-title":"Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment","volume":"21","author":"Betticher","year":"2013","journal-title":"Support Care Cancer"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejon.2013.02.004","article-title":"Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer","volume":"17","author":"van den Hurk","year":"2013","journal-title":"Eur J Oncol Nurs"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/apjon.apjon_4_19","article-title":"Scalp cooling in daily clinical practice for breast cancer patients undergoing curative chemotherapy:A multicenter interventional study","volume":"6","author":"Gianotti","year":"2019","journal-title":"Asia Pac J Oncol Nurs"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases:Systematic review and meta-analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jdv.14612","article-title":"Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia:A review of controlled clinical trials","volume":"32","author":"Shah","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fonc.2019.00733","article-title":"Efficacy of scalp cooling in preventing and recovering from chemotherapy-induced alopecia in breast cancer patients:The HOPE study","volume":"9","author":"Kinoshita","year":"2019","journal-title":"Front Oncol"},{"key":"R27-20240829","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/ijc.IJC_581_17","article-title":"The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting","volume":"55","author":"Saad","year":"2018","journal-title":"Indian J Cancer"},{"key":"R28-20240829","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer:The SCALP randomized clinical trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"key":"R29-20240829","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-014-3231-0","article-title":"No effect of scalp cooling on survival among women with breast cancer","volume":"149","author":"Lemieux","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R30-20240829","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.breast.2019.12.004","article-title":"\u201cRandomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia\u201d","volume":"49","author":"Bajpai","year":"2020","journal-title":"Breast"},{"key":"R31-20240829","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer:Incidence, characteristics, and prevention with scalp cooling","volume":"171","author":"Mart\u00edn","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R32-20240829","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R33-20240829","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers11111791","article-title":"Breast cancer in young women:Status quo and advanced disease management by a predictive, preventive, and personalized approach","volume":"11","author":"Kudela","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R34-20240829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/2278-330X.208859","article-title":"Breast cancer in young women:A retrospective study from tertiary care center of north India","volume":"6","author":"Sharma","year":"2017","journal-title":"South Asian J Cancer"},{"key":"R35-20240829","doi-asserted-by":"crossref","first-page":"198","DOI":"10.12688\/f1000research.4340.1","article-title":"Current treatment of early breast cancer:Adjuvant and neoadjuvant therapy","volume":"3","author":"Miller","year":"2014","journal-title":"F1000Res"},{"key":"R36-20240829","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.7314\/APJCP.2015.16.14.5655","article-title":"Comparing role of two chemotherapy regimens, CMF and anthracycline-based, on breast cancer survival in the eastern mediterranean region and Asia by multivariate mixed effects models:A meta-analysis","volume":"16","author":"Ghanbari","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R37-20240829","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Tr\u00fceb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"R38-20240829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41416-019-0520-8","article-title":"Preventing chemotherapy-induced alopecia:A prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines","volume":"121","author":"Munzone","year":"2019","journal-title":"Br J Cancer"},{"issue":"no. 15_suppl","key":"R39-20240829","first-page":"e22196","article-title":"\u201cSensor-controlled scalp cooling for chemotherapy-induced alopecia:Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and\/or taxanes in the neoadjuvant or adjuvant setting.,\u201dJCO,","volume":"36","author":"Kurbacher","year":"2018"},{"key":"R40-20240829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000501393","article-title":"EVA-scalp:Evaluation of patient satisfaction with a scalp cooling device to prevent chemotherapy-induced alopecia in breast cancer patients","volume":"15","author":"Bitto","year":"2020","journal-title":"Breast Care (Basel)"},{"key":"R41-20240829","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"key":"R43-20240829","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","article-title":"Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia","volume":"18","author":"Komen","year":"2013","journal-title":"Oncologist"},{"key":"R44-20240829","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.1016\/j.ctarc.2020.100280","article-title":"Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia-A single center prospective study","volume":"26","author":"Kate","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"R45-20240829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejon.2003.10.006","article-title":"A multicentre study to determine the efficacy and patient acceptability of the Paxman scalp cooler to prevent hair loss in patients receiving chemotherapy","volume":"8","author":"Massey","year":"2004","journal-title":"Eur J Oncol Nurs"},{"key":"R47-20240829","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00520-016-3084-7","article-title":"Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia","volume":"24","author":"Komen","year":"2016","journal-title":"Support Care Cancer"},{"key":"R48-20240829","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00520-018-4432-6","article-title":"Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia:A randomised trial in patients with breast cancer treated with adjuvant chemotherapy","volume":"27","author":"Komen","year":"2019","journal-title":"Support Care Cancer"},{"key":"R49-20240829","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clbc.2015.01.003","article-title":"Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy","volume":"15","author":"Cigler","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R50-20240829","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/idoj.IDOJ_471_18","article-title":"A descriptive study to analyze chemotherapy-induced hair loss and its psychosocial impact in adults:Our experience from a tertiary care hospital","volume":"10","author":"Saraswat","year":"2019","journal-title":"Indian Dermatol Online J"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_345_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:21:34Z","timestamp":1787768494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_345_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_345_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}